Opioid Use After Laparoscopic Salpingectomy
Launched by JOHNS HOPKINS UNIVERSITY · May 23, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how well different pain management methods work for women who are having a laparoscopic salpingectomy, a minimally invasive procedure that involves removing the fallopian tubes for sterilization. The main goal is to see if using a combination of non-opioid medications can control pain just as well as using opioids (strong painkillers) after surgery. Researchers believe that with proper guidance and using various pain relief options, women may not need opioid prescriptions at all.
To participate in this study, women must be 18 years or older and scheduled for a laparoscopic salpingectomy for benign reasons. However, those with chronic pain conditions, such as fibromyalgia, or who have been using opioids for a long time are not eligible. Participants will receive information on managing pain and will be monitored for their pain levels after the surgery. This trial is currently recruiting, and it aims to improve post-operative care while reducing reliance on opioids, which can have risks and side effects.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Individuals with a fallopian tube (unilateral and/or bilateral)
- • Age 18 years old and above
- • Undergoing minimally invasive (laparoscopic or robotic) unilateral or bilateral salpingectomy or other tubal sterilization procedure as the primary procedure
- • Benign indications for salpingectomy/tubal sterilization
- • Agreeing to participate
- Exclusion Criteria:
- • Chronic pain syndromes patients including fibromyalgia
- • Patients currently on long-term (i.e. for more than three months) opioid use
- • Conversion to laparotomy
- • Allergy or other contraindication to the prescribed medications such as acetaminophen or oxycodone
- • Salpingectomy that occurs in conjunction with a major Gyn surgery (i.e. hysterectomy, etc)
- • Salpingectomy performed for treatment of ectopic pregnancy
- • Patients with a history of gastritis and/or GI bleeding
About Johns Hopkins University
Johns Hopkins University, a prestigious research institution located in Baltimore, Maryland, is renowned for its commitment to advancing medical science and public health through innovative clinical trials. With a rich history of groundbreaking research and a multidisciplinary approach, the university's clinical trial initiatives focus on translating scientific discoveries into effective treatments and interventions. Leveraging state-of-the-art facilities and a collaborative network of experts, Johns Hopkins University conducts rigorous clinical studies that aim to improve patient outcomes and address critical health challenges. Its dedication to ethical standards and participant safety underscores its role as a leader in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Baltimore, Maryland, United States
Patients applied
Trial Officials
Mostafa Borahay, MD
Principal Investigator
Johns Hopkins University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported